Stockreport

Stoke Therapeutics: The First Gene Therapy For Dravet Syndrome [Seeking Alpha]

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report
PDF Investing Group Leader Follow Summary STOK's zorevunersen shows strong efficacy in reducing seizures but has safety concerns, particularly elevated CSF protein le [Read more]